Mason NL
Department of Neuropsychology & Psychopharmacology, Faculty of Psychology & Neuroscience, Maastricht University, Maastricht, The Netherlands.
PreprintPsilocybin
Circulating MicroRNAs and Their Associations with Neurotrophic, Inflammatory and Glutamate Markers in Healthy Volunteers
ArticlePsilocybin
Psychedelics and women's mental health: the effects of female sex hormones on psychedelics' efficacy and tolerability.
PreprintPsilocybin
Sex Differences in Acute Responses to Psychedelics: Evidence for Greater Subjective Intensity and Impairment in Female Participants
ArticleAyahuasca
Brain-body integromics of the ayahuasca experience.
ArticlePsilocybin
An international mega-analysis of psychedelic drug effects on brain circuit function.
ArticlePsilocybin
Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin.
PreprintPsilocybin
Unmixing the Psychedelic Connectome: Brain Network Traits of Psilocybin
PreprintPsilocybin
Neurocomputational evidence of sustained Self-Other mergence after psychedelics
ArticleLSD
A randomised placebo-controlled study of the effects of lysergic acid diethylamide microdosing (15 μg) on pain perception in healthy volunteers.
ArticleDMT
Evaluation of the peak experience scale as a rapid assessment tool for the strength of a psychoactive experience with 5-MeO-DMT.
ArticleDMT
Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness.
ArticlePsilocybin
Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression.
ArticlePsychedelics
Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study.
ArticleAyahuasca
Ayahuasca enhances the formation of hippocampal-dependent episodic memory without impacting false memory susceptibility in experienced ayahuasca users: An observational study.
PreprintPsilocybin
The forgotten psychedelic: Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin
PreprintPsilocybin
A virtual clinical trial of psychedelics to treat patients with disorders of consciousness
ArticleLSD
Inter-individual variability in neural response to low doses of LSD.
ArticlePsilocybin
Psilocybin and 2C-B at Encoding Distort Episodic Familiarity.
ArticlePsilocybin
Dynamic Functional Hyperconnectivity After Psilocybin Intake Is Primarily Associated With Oceanic Boundlessness.
ArticlePsilocybin
The unique neural signature of your trip: Functional connectome fingerprints of subjective psilocybin experience.
ArticlePsychedelics
Psychedelic Research as a Career Path: A Roundtable Discussion with Early Career Researchers in the Field.
ArticleAyahuasca
Shared functional connectome fingerprints following ritualistic ayahuasca intake.
ArticlePsilocybin
Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans.
ArticleAyahuasca
Cortical structural differences following repeated ayahuasca use hold molecular signatures.
PreprintPsilocybin
Dynamic Functional Hyperconnectivity after Psilocybin Intake is Primarily Associated with Oceanic Boundlessness
ArticleAyahuasca
Altered State of Consciousness and Mental Imagery as a Function of N, N-dimethyltryptamine Concentration in Ritualistic Ayahuasca Users.
ArticlePsilocybin
Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study.
ArticleDMT
A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression.
ArticlePsilocybin
Assessment of the Acute Effects of 2C-B vs. Psilocybin on Subjective Experience, Mood, and Cognition.
PreprintPsilocybin
The Unique Neural Signature of Your Trip: Functional Connectome Fingerprints of Subjective Psilocybin Experience
PreprintPsilocybin
Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition
PreprintAyahuasca
Ritualistic use of ayahuasca enhances a shared functional connectome identity with others
ArticlePsychedelics
Analgesic potential of macrodoses and microdoses of classical psychedelics in chronic pain sufferers: a population survey.
ArticlePsilocybin
Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees.
ArticlePsilocybin
Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.
ArticleLSD
The use patterns of novel psychedelics: experiential fingerprints of substituted phenethylamines, tryptamines and lysergamides.
ArticleAyahuasca
Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience.
ArticleDMT
The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT).
PreprintPsilocybin
Persisting decreases in state and trait anxiety post-psilocybin: A naturalistic, observational study among retreat attendees
ArticleLSD
LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking.
ArticleDMT
A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers.
ArticleAyahuasca
Persisting Effects of Ayahuasca on Empathy, Creative Thinking, Decentering, Personality, and Well-Being.
ArticlePsilocybin
Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics.
ArticlePsilocybin
Spontaneous and deliberate creative cognition during and after psilocybin exposure.
ArticleAyahuasca
A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats.
ArticleLSD
Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants.
ArticleLSD
Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study.
ArticleLSD
Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers.
ArticleLSD
A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers.
ArticlePsilocybin
Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin.
ArticlePsilocybin
Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers.
ArticlePsilocybin
Motives and Side-Effects of Microdosing With Psychedelics Among Users.
ArticleAyahuasca